Tuberculosis Research Today is a free monthly online journal that collates and summarizes the latest research about Tuberculosis, including details on symptoms, causes, treatment, pulmonary, mycobacterium.

Volume 4 (2007), Issue 7 (July)

1. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
   Pediatrics, 120(1): 90-9. [Abstract] [Full-text]
2. Ruptured mycotic abdominal aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette-Guérin.
   J Vasc Surg, 46(1): 131-4. [Abstract] [Full-text]
3. Feasibility of commercial interferon-gamma-based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high bacille Calmette-Guérin vaccination coverage.
   Clin Microbiol Infect, 13(8): 836-8. [Abstract] [Full-text]
4. Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection.
   Immunology, 121(4): 508-17. [Abstract] [Full-text]
5. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
   J Infect Dis, 196: S86-107. [Abstract] [Full-text]
6. Diagnostic and management challenges for childhood tuberculosis in the era of HIV.
   J Infect Dis, 196: S76-85. [Abstract] [Full-text]
7. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.
   J Infect Dis, 196: S63-75. [Abstract] [Full-text]
8. Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities.
   J Infect Dis, 196: S52-62. [Abstract] [Full-text]
9. Tuberculosis and HIV infection: the global setting.
   J Infect Dis, 196: S5-14. [Abstract] [Full-text]
10. Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials.
    J Infect Dis, 196: S46-51. [Abstract] [Full-text]
11. New tuberculosis therapeutics: a growing pipeline.
    J Infect Dis, 196: S28-34. [Abstract] [Full-text]
12. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era.
    J Infect Dis, 196: S15-27. [Abstract] [Full-text]
13. Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies.
    J Infect Dis, 196: S114-23. [Abstract] [Full-text]
14. Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment.
    J Infect Dis, 196: S108-13. [Abstract] [Full-text]
15. Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results.
    J Infect, 55(2): 169-73. [Abstract] [Full-text]
16. QuantiFERON-TB Gold test in the identification of latent tuberculosis infection in immigrants.
    J Infect, 55(2): 164-8. [Abstract] [Full-text]
17. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis.
    Clin Infect Dis, 45(4): 428-35. [Abstract] [Full-text]
18. Nasopharyngeal aspiration for diagnosis of pulmonary tuberculosis.
    Arch Dis Child, 92(8): 693-6. [Abstract] [Full-text]
19. Predictors of adherence to latent tuberculosis infection therapy in Latino immigrants.
    J Community Health Nurs, 24(3): 191-8. [Abstract] [Full-text]
20. Emergent heterogeneity in declining tuberculosis epidemics.
    J Theor Biol, 247(4): 765-74. [Abstract] [Full-text]

© 2004-2008 Tuberculosis Research Today. All Rights Reserved.